Nova Eye Medical Ltd
Company Profile
Business description
Nova Eye Medical Ltd is a medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of its revenue from the United States of America.
Contact
107 Rundle Street
Kent Town
AdelaideSA5067
AUST: +61 883620193
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2025
Employees
301
Stocks News & Analysis
stocks
CSL remains favourite, but biotech field broadening
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,052.70 | 80.40 | -0.99% |
CAC 40 | 7,858.83 | 17.53 | -0.22% |
DAX 40 | 22,390.84 | 149.14 | -0.66% |
Dow JONES (US) | 42,225.32 | 235.36 | 0.56% |
FTSE 100 | 8,608.48 | 26.32 | -0.30% |
HKSE | 22,843.50 | 359.03 | -1.55% |
NASDAQ | 17,601.05 | 151.16 | 0.87% |
Nikkei 225 | 34,688.87 | 1,037.00 | -2.90% |
NZX 50 Index | 12,338.57 | 18.38 | 0.15% |
S&P 500 | 5,670.97 | 37.90 | 0.67% |
S&P/ASX 200 | 7,859.70 | 74.80 | -0.94% |
SSE Composite Index | 3,342.94 | 7.18 | -0.21% |